Determination of Lorazepam in Plasma of Patients during Status Epilepticus by High-Performance Liquid Chromatography
- 1 June 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 10 (2) , 172-176
- https://doi.org/10.1097/00007691-198802000-00010
Abstract
A reversed-phase high-performance liquid chromatography method for the determination of lorazepam in human plasma has been developed. The method was used to analyze plasma samples obtained from patients who were treated with 0.1 mg/kg of intravenous lorazepam during status epilepticus. The detection limit for lorazepam was 5 ng/ml. None of the most commonly used antiepileptic drugs interfere with this lorazepam analysis.This publication has 3 references indexed in Scilit:
- Efficiency and Cleanliness of Ether Extraction for Benzodiazepines in Blood Samples Treated with Aqueous Ammonia Compared with Other Methods for the Purpose of HPLC AssayJournal of the Forensic Science Society, 1985
- High-performance liquid chromatographic determination of lorazepam in monkey plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Analysis of lorazepam and its glucoronide metabolite by electron-capture gas—liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1978